Company Overview

Update
Funding:
$14M
Categories:
Biotechnology
Description:
Telsar Pharma develops Astellas drugs for common inflammatory bowel diseases.

Detailed Description

Update

Telsar Pharma Inc., a new company that will develop an Astellas drug for a common inflammatory bowel disease.

Funding Rounds (1) - $14M

Update

Investors (1)

Update